tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RXRX Stock Latest News

Strategic Growth and Unique Positioning Drive Buy Rating for Recursion Pharmaceuticals
RatingsStrategic Growth and Unique Positioning Drive Buy Rating for Recursion Pharmaceuticals
2d ago
RXRX
Recursion Pharmaceuticals management to meet with Needham
PremiumThe Fly
Recursion Pharmaceuticals management to meet with Needham
4d ago
RXRX
Buy Recommendation for Recursion Pharmaceuticals: Strong Position in AI-Driven Drug Discovery with Strategic Acquisitions and Financial Stability
PremiumRatings
Buy Recommendation for Recursion Pharmaceuticals: Strong Position in AI-Driven Drug Discovery with Strategic Acquisitions and Financial Stability
7d ago
RXRX
Private Markets: Anthropic raises $13B Series F at $183B post-money valuation
PremiumThe Fly
Private Markets: Anthropic raises $13B Series F at $183B post-money valuation
7d ago
AI
GS
Rallybio receives $12.5M equity milestone payment from Recursion Pharmaceuticals
PremiumThe Fly
Rallybio receives $12.5M equity milestone payment from Recursion Pharmaceuticals
9d ago
RLYB
RXRX
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
25d ago
ING
AMPY
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
28d ago
ETH
KGC
Nvidia discloses increased CoreWeave stake of $3.96B
Premium
The Fly
Nvidia discloses increased CoreWeave stake of $3.96B
29d ago
ARM
APLD
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
29d ago
ING
CHYM
Recursion Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany Announcements
Recursion Pharmaceuticals Reports Q2 2025 Financial Results
1M ago
RXRX
Recursion Pharmaceuticals’ Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Recursion Pharmaceuticals’ Earnings Call Highlights Progress and Challenges
1M ago
RXRX
Recursion Pharmaceuticals: Balancing AI Advancements with Financial Prudence Justifies Hold Rating
PremiumRatings
Recursion Pharmaceuticals: Balancing AI Advancements with Financial Prudence Justifies Hold Rating
1M ago
RXRX
Recursion Pharmaceuticals: Strong Financial Position and Strategic Focus Justify Buy Rating
PremiumRatingsRecursion Pharmaceuticals: Strong Financial Position and Strategic Focus Justify Buy Rating
1M ago
RXRX
Recursion Pharmaceuticals Reports Q2 2025 Financial Results
Premium
Company Announcements
Recursion Pharmaceuticals Reports Q2 2025 Financial Results
1M ago
8K
RXRX
Recursion Pharmaceuticals reports Q2 EPS (41c), consensus (35c)
Premium
The Fly
Recursion Pharmaceuticals reports Q2 EPS (41c), consensus (35c)
1M ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
RXRX
Recursion Pharmaceuticals rises 10.7%
PremiumThe Fly
Recursion Pharmaceuticals rises 10.7%
2M ago
RXRX
Recursion Pharmaceuticals rises 16.8%
PremiumThe Fly
Recursion Pharmaceuticals rises 16.8%
2M ago
RXRX
Unusually active option classes on open July 21st
PremiumThe Fly
Unusually active option classes on open July 21st
2M ago
S
HOG
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe FlyRecursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
RXRX
Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
Premium
The Fly
Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
2M ago
BA
EXK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >